Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

How Does Smart Money Feel About Acura Pharmaceuticals, Inc. (ACUR)?

Page 1 of 2

Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the third quarter. Among them, Valeant and Micron ranked among the top 30 picks and both lost around 20%. Citigroup, which was the third most popular stock, lost 10% amid uncertainty regarding the interest rates. Nevertheless, our research shows that most of the stocks that smart money likes historically generate strong risk-adjusted returns. This is why following the smart money sentiment is a useful tool for identifying the next stock to invest in.

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) shareholders have witnessed an increase in hedge fund sentiment lately. ACUR was in 4 hedge funds’ portfolios at the end of September. There was 1 hedge fund in our database with ACUR holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why, at the end of this article, we will examine companies such as Luna Innovations Incorporated (NASDAQ:LUNA), SMTC Corporation (USA) (NASDAQ:SMTX), and Deswell Industries, Inc. (NASDAQ:DSWL) to gather more data points.

Follow Acura Pharmaceuticals Inc (NASDAQ:ACUR)
Trade (NASDAQ:ACUR) Now!

In the financial world, there are numerous signals stock market investors put to use to assess publicly traded companies. A duo of the best signals is composed of hedge fund and insider trading interest. Our researchers have shown that, historically, those who follow the best picks of the top hedge fund managers can outperform the S&P 500 by a superb margin (see the details here).

Now, let’s check out the new action encompassing Acura Pharmaceuticals, Inc. (NASDAQ:ACUR).

How are hedge funds trading Acura Pharmaceuticals, Inc. (NASDAQ:ACUR)?

At the end of the third quarter, a total of 4 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 300% from the previous quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a select group of notable hedge fund managers who were upping their stakes substantially (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Deerfield Management, managed by James E. Flynn, holds the number one position in Acura Pharmaceuticals, Inc. (NASDAQ:ACUR). Deerfield Management has a $2.4 million position in the stock, comprising 0.1% of its 13F portfolio. On Deerfield Management’s heels is Sabby Capital, led by Hal Mintz, holding a $1.7 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Remaining peers that hold long positions consist of Jim Simons’s Renaissance Technologies, and Glenn Russell Dubin’s Highbridge Capital Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!